image: Schematic showing the use of a smartphone to control genetically engineered cells as a diabetes treatment in mice. This material relates to a paper that appeared in the April 26, issue of Science Translational Medicine, published by AAAS. The paper, by J. Shao at East China Normal University in Shanghai, China, and colleagues was titled, 'Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice.' view more
Credit: J. Shao <i>et al., Science Translational Medicine</i> (2017)